Abstract | BACKGROUND: OBJECTIVE: METHODS: RESULTS: In patients with psoriasis, the baseline median PASI score was 10.8 and baseline YKL-40 was 45 μg/L. Seventeen per cent had elevated plasma YKL-40 compared with healthy subjects. Baseline PASI and YKL-40 were not correlated (rho = 0.14, P = 0.347) and YKL-40 and hs-CRP remained unchanged after treatment. In patients with psoriatic arthritis, the median pretreatment YKL-40 was 112 μg/L and 43% had elevated YKL-40. YKL-40 decreased in 33 patients who responded to adalimumab (from 112 μg/L to 68 at 48 weeks, P = 0.007). Hs-CRP decreased (from 4.65 mg/L to 0.91, P = 0.013) in the responders. In the non-responders (n = 9), YKL-40 and hs-CRP remained unchanged. CONCLUSIONS:
|
Authors | P Jensen, C Wiell, K Milting, R P Poggenborg, M Østergaard, J S Johansen, L Skov |
Journal | Journal of the European Academy of Dermatology and Venereology : JEADV
(J Eur Acad Dermatol Venereol)
Vol. 27
Issue 7
Pg. 815-9
(Jul 2013)
ISSN: 1468-3083 [Electronic] England |
PMID | 22621388
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology. |
Chemical References |
- Adipokines
- Biomarkers
- CHI3L1 protein, human
- Chitinase-3-Like Protein 1
- Lectins
- C-Reactive Protein
|
Topics |
- Adipokines
(blood)
- Adult
- Aged
- Aged, 80 and over
- Arthritis, Psoriatic
(blood, diagnosis)
- Biomarkers
(blood)
- C-Reactive Protein
(analysis)
- Chitinase-3-Like Protein 1
- Female
- Humans
- Lectins
(blood)
- Male
- Middle Aged
- Psoriasis
(blood)
- Young Adult
|